Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. - Wikidata - wikimedia - TriplyDB

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

http://www.wikidata.org/entity/Q35023409

about

Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients Delivering care to long-term adult survivors of hematopoietic cell transplantation.National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention.A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity Late effects of blood and marrow transplantation.Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis A novel self-lipid antigen targets human T cells against CD1c(+) leukemias Current issues in chronic graft-versus-host disease.Failure-free survival after initial systemic treatment of chronic graft-versus-host disease Treatment of chronic graft-versus-host disease with bortezomib Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic Relationships among symptoms, psychosocial factors, and health-related quality of life in hematopoietic stem cell transplant survivors Long-term follow-up after allogeneic stem cell transplantation Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease.Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients Subsequent malignant neoplasms after hematopoietic cell transplantation.Self-regulatory fatigue in hematologic malignancies: impact on quality of life, coping, and adherence to medical recommendations Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation.Arrhythmias in the setting of hematopoietic cell transplants.Survival of patients who develop solid tumors following hematopoietic stem cell transplantation.Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.Self-regulatory fatigue, quality of life, health behaviors, and coping in patients with hematologic malignancies.Health-Related Quality of Life among Children and Adolescents during Hematopoietic Stem Cell Transplant Recovery.Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation.Not all anti-T lymphocyte globulin preparations are suitable for use in aplastic anemia: significantly inferior results with jurkat cell-reactive anti-T lymphocyte globulin in clinical practice Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.

P2860

Q24626202-D79C1E5B-3F85-4F00-B94E-5DA5CD8261BF Q26787230-A4F6DDD3-5826-4676-8AD1-DA03BBFC679D Q27021501-FEDA741C-8765-44FF-A6AD-FF42C56FC6B9 Q29248394-4DFCB7C2-90CC-489C-ACB0-42E86A02AE9C Q30252205-554FB426-C592-49C0-B084-3637AF03D327 Q33573863-24E36150-FA07-4EC4-9690-13043CB66E8F Q33574136-7A1365CE-6C0D-4787-B0BA-B61CE6E6497D Q33605503-726C7E1A-0FEE-45BC-AC84-8475D9A0C15D Q33625948-8C2E2762-4EAB-4576-BADE-DA8E000F9DC8 Q33689153-C17695E2-3A3B-427F-B428-003B05B954F9 Q33826848-8ED46E96-BD4C-4E46-A97D-79E501BAD977 Q33917187-A48CD7E7-9397-4668-BA84-DA247123FEC3 Q34077787-63E7D8AC-7B73-48BD-AF37-2D0361805E81 Q34137032-151D0C16-28AF-46E9-8E0E-16A237DF6CD9 Q34749365-5480A181-6E98-4C09-89A8-9251D1433E05 Q34817365-AF0E3A84-9320-4426-8C6A-3DF94DCE39D1 Q35033578-5801D9DB-1D3E-4254-A663-5ECDA350259D Q35104794-86DADE6D-BCD6-4AE9-8BDE-19EEDAB87347 Q35184667-CF934F10-8235-4F5E-9952-A6316C6FAAF6 Q35533376-ECBAF0D4-6F01-4635-8E8D-6B6AB61CE83B Q35571058-92ED1802-D7E4-4CDE-91B3-7DD39DE6301D Q35586614-958516D1-CEA0-4576-A1A4-C70D10D4121D Q35661304-060C3067-BB5A-468C-B666-A5B4F211E709 Q35665096-7B10FA50-78F4-40B7-A3F7-0D267AE10D9C Q35669073-CE605C40-511C-41BA-8B8F-278E7B1A27D3 Q35678455-006F3F18-0B42-4E35-A729-D17B7F66BAFF Q35679780-1784F734-CB2D-4136-8B93-2CD0DD404712 Q35724025-96F6EBD1-6A3A-4B89-ACCB-EF7BF708294E Q35757247-BE19FE2F-AFD2-4A70-8CEF-C02809F26DA5 Q35800814-14076E3F-7936-4823-ACC8-4ED9B23DD58A Q35958040-37F3422A-4732-4B78-937D-817A87D84D6F Q36021536-316F5B98-1660-4E3B-AB9D-D4A245B836EC Q36060706-950CF2BD-B5AF-4968-8486-B09D888938F3 Q36078279-1E14A1D3-86FE-47AD-81F7-45E5D7D04B80 Q36142947-0D933B6D-11CB-4FEC-8B38-8831F9F9A0B2 Q36164963-70E03D8E-B66D-43E1-96EB-EBD535B12607 Q36219840-B0252461-1129-40AD-A8BA-A085D04DAB24 Q36317960-79FE97C1-7647-4214-8632-CE2CD32FA9DE Q36395151-F64C03A1-6B1E-4BC3-9F87-A118A191A91F Q36440055-E2EF2DF0-F88D-4B6E-8F88-5174B7C9FAF1

P2860

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

http://www.wikidata.org/entity/Q35023409

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

@ast

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

@en

type

label

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

@ast

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

@en

prefLabel

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

@ast

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

@en

P1433

Q35023409-4A4255EF-A84B-46EB-AD5A-C9B7F2A1A5C9

P1476

Q35023409-F37FB6BE-8249-4BFB-8B79-5D6B92803BFA

P2093

Q35023409-0DCB712B-3672-4C49-BF2E-F95EABD5D2B5

Q35023409-461E6326-D268-4E17-B760-A5298E7B3F50

Q35023409-6CE90A72-41BB-413A-A53B-73412A56A5B0

Q35023409-88612A24-017F-43AE-B2EC-9B9A656B7828

Q35023409-95BBE76E-35F2-47AD-A739-96A2AA7149E4

Q35023409-BF6AAB99-82DF-4A97-943C-C36852D495A2

Q35023409-C892989B-D83B-48AF-AEBC-26C054BC9C57

Q35023409-CA7E70E4-81ED-4D7B-BB98-4D10EFB53A93

Q35023409-D2A480E0-F6B2-49BE-81B8-51509EDF2C68

Q35023409-E07F35D9-86DC-4E01-A0DD-30A9AA5CECF6

P2860

Q35023409-01379152-BEB2-46AA-B3F8-DD5E2DDD26F1

Q35023409-08A38E6B-7029-4331-8D75-4BA6225373A7

Q35023409-09BD9924-91E2-4D40-9997-A94C9C955137

Q35023409-0A988F93-6B5D-408B-978A-01227F7F2121

Q35023409-149AE62D-167D-4C2D-B531-0C3E4E4A841F

Q35023409-16867C99-360D-4C08-8606-5761375032E9

Q35023409-2D177BCF-8948-46CF-99C9-AD5F8F09869F

Q35023409-33357036-F96C-423F-A83D-88A48AB446CE

Q35023409-333FB08E-66D8-41AB-B6C4-CABA2E6C1F8C

Q35023409-55493AC4-A9E0-454C-9630-E443A066AD91

P304

Q35023409-AC071395-9206-46F4-B412-C6E715AA5435

P31

Q35023409-2AD291EA-D5C2-45E7-95B2-37AE794C2150

P356

Q35023409-404080DC-77F8-4A0B-B69F-2E70937150A8

P407

Q35023409-30FCBCDC-F56E-4B5F-99C9-780C9D52738F

P433

Q35023409-9E2A8FAC-B104-473F-9514-2EC1DF23FEFD

P478

Q35023409-1229DC9A-B7BF-4B5F-B9E7-C9258D7EF8B2

P50

Q35023409-040BADEC-6F43-483C-9E0C-C08871D79419

P577

Q35023409-4FAB43E2-FC6B-4910-8874-C60C0C793A9F

P698

Q35023409-0F3568F9-29E9-471B-88F7-4EF374CC4009

P932

Q35023409-1351C134-54B3-4C32-A7A6-D91B4923E195

P356

JCO.2010.33.7212

P1433

Journal of Clinical Oncology

P1476

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

@en

P2093

Brian Bolwell

http://www.w3.org/2001/XMLSchema#string

David Jacobsohn

http://www.w3.org/2001/XMLSchema#string

J Douglas Rizzo

http://www.w3.org/2001/XMLSchema#string

John R Wingard

http://www.w3.org/2001/XMLSchema#string

Kathleen A Sobocinski

http://www.w3.org/2001/XMLSchema#string

Mary M Horowitz

http://www.w3.org/2001/XMLSchema#string

Mohamed L Sorror

http://www.w3.org/2001/XMLSchema#string

Navneet S Majhail

http://www.w3.org/2001/XMLSchema#string

Ruta Brazauskas

http://www.w3.org/2001/XMLSchema#string

Zhiwei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls.

Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.

Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.

High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR.

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study

Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study

Temporal trends in cause-specific late mortality among 5-year survivors of childhood cancer.

Immune reconstitution: the major barrier to successful stem cell transplantation.

P304

2230-2239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.33.7212

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21464398

http://www.w3.org/2001/XMLSchema#string

P932

3107742

http://www.w3.org/2001/XMLSchema#string